Nilubol, N., Boufraqech, M., Zhang, L., Gaskins, K., Shen, M., Zhang, Y., . . . Kebebew, E. (2018). Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. Oncotarget.

Nilubol, Naris, Myriem Boufraqech, Lisa Zhang, Kelli Gaskins, Min Shen, Ya-Qin Zhang, Sudheer K. Gara, Christopher P. Austin, و Electron Kebebew. "Synergistic Combination of Flavopiridol and Carfilzomib Targets Commonly Dysregulated Pathways in Adrenocortical Carcinoma and Has Biomarkers of Response." Oncotarget 2018.

Nilubol, Naris, et al. "Synergistic Combination of Flavopiridol and Carfilzomib Targets Commonly Dysregulated Pathways in Adrenocortical Carcinoma and Has Biomarkers of Response." Oncotarget 2018.